Recent trends in the use of wearable sensors to capture endpoint data in multiple sclerosis clinical trials

被引:0
|
作者
Khurana, Laura [1 ]
Hughes, Lindsay [1 ]
Horak, Fay [2 ]
Sowalsky, Kristen [2 ]
机构
[1] ERT, Medford, MA USA
[2] ERT, Portland, OR USA
关键词
D O I
暂无
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
3090
引用
收藏
页码:S127 / S128
页数:2
相关论文
共 50 条
  • [21] The Use of Motor-Evoked Potentials in Clinical Trials in Multiple Sclerosis
    Fernandez, Victoria
    [J]. JOURNAL OF CLINICAL NEUROPHYSIOLOGY, 2021, 38 (03) : 166 - 170
  • [22] Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis
    Laura E. Baldassari
    John W. Rose
    [J]. Neurotherapeutics, 2017, 14 : 842 - 858
  • [23] Use of fluid biomarkers in ongoing Clinical Trials on Multiple Sclerosis (MS)
    Schilke, E.
    Remoli, G.
    Galimberti, M.
    Funelli, E.
    Fusco, M.
    Frigo, M.
    Ferrarese, C.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 694 - 695
  • [24] The Use of MR Imaging as an Outcome Measure in Multiple Sclerosis Clinical Trials
    Bermel, Robert A.
    Fisher, Elizabeth
    Cohen, Jeffrey A.
    [J]. NEUROIMAGING CLINICS OF NORTH AMERICA, 2008, 18 (04) : 687 - 701
  • [25] Daclizumab: Development, Clinical Trials, and Practical Aspects of Use in Multiple Sclerosis
    Baldassari, Laura E.
    Rose, John W.
    [J]. NEUROTHERAPEUTICS, 2017, 14 (04) : 842 - 858
  • [26] Clinical trials in multiple sclerosis: milestones
    Zhang, Yinan
    Salter, Amber
    Cutter, Gary
    Stuve, Olaf
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2018, 11
  • [27] Methodology of clinical trials in multiple sclerosis
    Mitsikostas, D. D.
    [J]. NEUROLOGICAL SCIENCES, 2006, 27 (Suppl 5) : S362 - S364
  • [28] Methodology of clinical trials in multiple sclerosis
    D. D. Mitsikostas
    [J]. Neurological Sciences, 2006, 27 : s362 - s364
  • [29] Evolution of clinical trials in multiple sclerosis
    Zhang, Yinan
    Salter, Amber
    Wallstroem, Erik
    Cutter, Gary
    Stueve, Olaf
    [J]. THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2019, 12